Hike in profits at H&R Wasag
Germany's H&R Wasag is forecasting higher-than-expected profits
in 2003, helped by a reduction in oil prices since the end of the
war in Iraq.
Pump makers under pressure
Escalating inflation rates and price pressures are hitting the
profit margins of positive displacement pump manufacturers and
inhibiting R&D, says new study.
Cambrex extends Ontak contract
Cambrex Bio Science has won an additional five-year contract to
manufacture Ontak, a biopharmaceutical product developed by Ligand
Safety syringes booming
The market for retractable syringes designed to prevent needlestick
injuries is set for explosive growth and could expand nearly
seven-fold by 2006, according to a new report.
Applera sues Roche over PCR
Switzerland's Roche is subject to a fresh legal challenge over its
patent position in polymerase chain reaction (PCR) testing, this
time from Applera unit Applied Biosystems.
Chugai to claim top spot for bio production
Chugai says it is building facilities that will give it the largest
bioreactor capacity for biologicals production - at 85,000L - of
any company in the world by 2007.
Pyrosequencing buys Biotage in US
Sweden's Pyrosequencing has entered into an agreement to buy
prification and separation specialist Biotage, a subsidiary of Dyax
of the USA, for $35 million.
Ireland's DPS sets out on European charge
DPS Engineering, an Irish engineering firm which specialises in
providing services to the pharmaceutical sector says it is planning
to create 250 jobs over the next five years as it continues a major
growth phase in its business in...
Roche to build $155m PCR facility
Roche is planning to spend $155 million on a new polymerase chain
reaction (PCR) manufacturing centre at its site in Branchburg, New
General Electric to share Amersham vision
Amersham has confirmed that its suitor is General Electric, which
has offered £5.7bn for the UK group. GE head says Biosciences
future is secure, at least in near-term.
Hermes hikes production capacity
Hermes Arzneimittel buys a second pharmaceutical manufacturing site
from Viatris in a move which triples the number of staff working on
Pharma and other process industries "throwing away money"
Process manufacturing industries are not responding to a clear need
to improve the information flow between the different parts of
their businesses leading to costly plant shutdowns, says a new
survey commissioned by BASF IT Services.
Amersham soars on takeover bid
After Amersham confirmed yesterday that it had received a bid from
an unnamed suitor wishing to buy the entire company, its shares
rose more than 16 per cent; both J&J and Roche are in the
MG exits chemicals business
MG Technologies has decided to sell off its chemicals businessesand
concentrate on process technology and components.
Rhodia CEO quits
Troubled chemicals group Rhodia sees its CEO depart as the company
announces another restructuring round that will see €600m in
divestments by end-2004.